SEC Form 4 · accession 0001645627-15-000005

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President · 10% Owner

Period of report

Aug 25, 2015

Accepted (ET)

Sep 16, 2015 · 10:19 am EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001528172

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Aug 25, 2015	P	100	$0.075	A	19,593,015	D
Common Stock	Aug 25, 2015	P	200	$0.075	A	19,593,215	D
Common Stock	Aug 25, 2015	P	100	$0.079	A	19,593,315	D
Common Stock	Aug 25, 2015	P	100	$0.079	A	19,593,415	D
Common Stock	Aug 25, 2015	P	100	$0.08	A	19,593,515	D
Common Stock	Aug 26, 2015	P	200	$0.08	A	19,593,715	D
Common Stock	Aug 27, 2015	P	230	$0.08	A	19,593,945	D
Common Stock	Aug 27, 2015	P	500	$0.08	A	19,594,445	D
Common Stock	Aug 28, 2015	P	100	$0.08	A	19,594,545	D
Common Stock	Aug 31, 2015	P	270	$0.08	A	19,594,815	D
Common Stock	Aug 31, 2015	P	100	$0.08	A	19,594,915	D
Common Stock par value .0001	Aug 31, 2015	P	100	$0.08	A	19,595,015	D
Common Stock	Aug 31, 2015	P	100	$0.08	A	19,595,115	D
Common Stock	Sep 1, 2015	P	1,000	$0.0799	A	19,596,115	D
Common Stock	Sep 1, 2015	P	100	$0.07	A	19,596,215	D
Common Stock	Sep 1, 2015	P	100	$0.071	A	19,596,315	D
Common Stock	Sep 2, 2015	P	100	$0.07	A	19,596,415	D
Common Stock	Sep 2, 2015	P	135	$0.071	A	19,596,550	D
Common Stock	Sep 3, 2015	P	100	$0.0799	A	19,596,650	D
Common Stock	Sep 4, 2015	P	260	$0.079	A	19,596,910	D
Common Stock	Sep 4, 2015	P	100	$0.075	A	19,597,010	D
Common Stock	Sep 8, 2015	P	500	$0.07	A	19,597,510	D
Common Stock	Sep 9, 2015	P	500	$0.07	A	19,598,010	D
Common Stock	Sep 9, 2015	P	500	$0.073	A	19,598,510	D

No Table II lines on this filing.